Verastem, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $30.9M | $10.0M | — | $2.6M | $2.1M |
| Selling, general & administrative | $81.1M | $43.6M | $30.7M | $25.0M | $24.1M |
| Research and development | $114.6M | $81.3M | $61.4M | $50.6M | $39.3M |
| Operating income | -$170.1M | -$115.0M | -$92.1M | -$72.9M | -$61.4M |
| Interest expense | $1.1M | $4.6M | $4.1M | $2.1M | $10.0M |
| Pretax income | -$209.5M | -$130.5M | -$87.4M | -$73.8M | -$71.2M |
| Income tax expense | — | $185,000 | — | $0 | $0 |
| Net income | -$209.5M | -$130.6M | -$87.4M | -$73.8M | -$71.2M |
| Balance Sheet | |||||
| Cash and equivalents | $205.0M | $88.8M | $77.9M | $74.9M | $21.3M |
| Current assets | $223.4M | $95.0M | $143.7M | $92.9M | $105.7M |
| Total assets | $246.4M | $101.5M | $149.7M | $95.0M | $108.7M |
| Current liabilities | $72.3M | $31.0M | $26.4M | $21.7M | $18.6M |
| Total liabilities | $189.2M | $130.4M | $71.2M | $47.7M | $21.1M |
| Total debt | — | $40.0M | $40.0M | $25.0M | — |
| Stockholders' equity | $57.2M | -$28.9M | $57.4M | $47.4M | $87.6M |
| Cash Flow Statement | |||||
| Cash from operations | -$137.5M | -$104.8M | -$86.5M | -$63.7M | -$53.5M |
| Depreciation and amortization | $30,000 | $26,000 | $62,000 | $118,000 | $206,000 |
| Stock-based compensation | $9.4M | $7.3M | $5.9M | $6.0M | $7.7M |
| Capital expenditure | — | $28,000 | $7,000 | — | $196,000 |
| Free cash flow | — | -$104.8M | -$86.5M | — | -$53.7M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 87.9M · Free float 91.8%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.